deoxyepinephrine has been researched along with Hypertension in 7 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These studies were performed in patients with essential hypertension who were maintained on a constant sodium intake (100 mmol/day), before and after 5 days of treatment with ibopamine, an orally active dopamine analogue." | 7.67 | Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension. ( Ambrosi, B; Ardeleani, G; Ferraris, P; Morganti, A; Quorso, P; Sala, C; Venegoni, P; Zanchetti, A, 1988) |
| " These studies were performed in patients with essential hypertension who were maintained on a constant sodium intake (100 mmol/day), before and after 5 days of treatment with ibopamine, an orally active dopamine analogue." | 3.67 | Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension. ( Ambrosi, B; Ardeleani, G; Ferraris, P; Morganti, A; Quorso, P; Sala, C; Venegoni, P; Zanchetti, A, 1988) |
| "Essential hypertension is a major factor for myocardial infarction, heart failure and kidney failure." | 2.43 | A new approach for treatment of hypertension: modifying D1 dopamine receptor function. ( Felder, RA; Jose, PA; Zeng, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, C | 1 |
| Felder, RA | 1 |
| Jose, PA | 1 |
| Niwa, M | 1 |
| Ozaki, M | 1 |
| Maemura, S | 1 |
| Finch, L | 1 |
| Hersom, A | 1 |
| Hicks, P | 1 |
| Girbes, AR | 1 |
| van Veldhuisen, DJ | 1 |
| Smit, AJ | 1 |
| Sala, C | 1 |
| Morganti, A | 1 |
| Ferraris, P | 1 |
| Ardeleani, G | 1 |
| Venegoni, P | 1 |
| Quorso, P | 1 |
| Ambrosi, B | 1 |
| Zanchetti, A | 1 |
| Sato, Y | 1 |
| Fujita, T | 1 |
| Balazovjech, I | 1 |
| Mikulecký, M | 1 |
| Sedlák, P | 1 |
| Kratochvílová, H | 1 |
2 reviews available for deoxyepinephrine and Hypertension
| Article | Year |
|---|---|
A new approach for treatment of hypertension: modifying D1 dopamine receptor function.
Topics: Antihypertensive Agents; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; G-Protein-Couple | 2006 |
[High performance liquid chromatography-electrochemical detection (LC-EC) and its clinical use, with special reference to the detection of biogenic amines].
Topics: Animals; Biogenic Amines; Catecholamines; Chromatography, High Pressure Liquid; Deoxyepinephrine; Hu | 1984 |
5 other studies available for deoxyepinephrine and Hypertension
| Article | Year |
|---|---|
Studies on the hypotensive action of alpha-methyldopamine.
Topics: Animals; Blood Pressure; Cats; Deoxyepinephrine; Depression, Chemical; Desipramine; Dopamine; Drug I | 1975 |
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenol | 1991 |
Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
Topics: Aldosterone; Atrial Natriuretic Factor; Deoxyepinephrine; Dopamine; Humans; Hypertension; Metoclopra | 1988 |
[Drug resistance and withdrawal syndrome--study on receptors].
Topics: Animals; Clonidine; Deoxyepinephrine; Drug Resistance; Humans; Hypertension; Receptors, Opioid; Subs | 1985 |
[Falsely elevated urinary catecholamine excretion in alpha-methyldopa therapy].
Topics: Adrenal Gland Neoplasms; Catecholamines; Deoxyepinephrine; Diagnostic Errors; Dopamine; Humans; Hype | 1985 |